Clinical trials are required to prove the chemopreventive worth of statins

Arch Intern Med. 2006 May 22;166(10):1143; author reply 1144. doi: 10.1001/archinte.166.10.1143-a.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Breast Neoplasms / prevention & control*
  • Chemoprevention / methods
  • Clinical Trials as Topic*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Middle Aged

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors